Trial
NCT00944229
The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
GlaxoSmithKline
Condition
Heart Failure
Intervention
LOVAZA (Omega-3)
Why stopped
PI left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-05-25